JK Agri Genetics shareholders approve FY26 results and Pandit's reappointment
JK Agri Genetics Limited confirmed that all resolutions at its 26th AGM on July 31, 2026, were passed with overwhelming support. Shareholders approved the FY26 financial statements and the reappointment of Kuldeep Kumar Pandit as Director and Whole-time Director. The meeting was conducted via Video Conferencing with e-voting facilities provided by CDSL.

*this image is generated using AI for illustrative purposes only.
JK Agri Genetics shareholders approved all resolutions presented at its 26th Annual General Meeting (AGM), including the adoption of financial statements for the fiscal year ended March 31, 2026, and the reappointment of Kuldeep Kumar Pandit to key leadership roles. The meeting, held on July 31, 2026, via Video Conferencing, saw strong support from both promoter and public shareholders, with over 99% of votes cast in favor of each agenda item.
The AGM was conducted in compliance with Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The voting process included remote e-voting and e-voting during the meeting, scrutinized by P. K. Sarawagi of M/s P. Sarawagi & Associates, who served as the independent Scrutinizer. Central Depository Services (India) Limited (CDSL) facilitated the electronic voting system.
Voting Results Overview
A total of 4,636,963 shares were eligible to vote, representing 6,772 shareholders on the record date. Approximately 78.34% of outstanding shares participated in the voting process. The promoter group, holding 3,390,037 shares, voted unanimously in favor of all resolutions. Public non-institutional shareholders also showed significant support, with participation rates around 19.45%.
| Resolution | Description | Votes In Favor | Votes Against | % Support |
|---|---|---|---|---|
| 1 | Adoption of Audited Financial Statements for FY26 | 3,630,877 | 1,674 | 99.95% |
| 2 | Reappointment of Kuldeep Kumar Pandit as Director | 3,630,577 | 1,974 | 99.95% |
| 3 | Reappointment of Pandit as Whole-time Director | 3,630,577 | 1,974 | 99.95% |
Key Resolutions Passed
The first ordinary resolution concerned the adoption of the Audited Standalone Financial Statements and the Reports of the Board of Directors and Auditors for the financial year ended March 31, 2026. Additionally, shareholders approved the Audited Consolidated Financial Statements and the Report of the Auditors for the same period. This resolution received 3,630,877 votes in favor and 1,674 votes against.
The second ordinary resolution involved the reappointment of Shri Kuldeep Kumar Pandit (DIN: 08381208) as a Director, who retires by rotation. Being eligible, he offered himself for re-appointment. This resolution secured 3,630,577 votes in favor and 1,974 votes against.
The third resolution, classified as a special resolution, approved the reappointment of Shri Kuldeep Kumar Pandit as Whole-time Director with the designation "President & Director" for a period of three years, effective November 24, 2026. This resolution also garnered 3,630,577 votes in favor and 1,974 votes against.
Procedural Compliance
The remote e-voting period commenced on July 28, 2026, at 10:00 a.m. and concluded on July 30, 2026, at 5:00 p.m. Members holding shares as of the cut-off date, July 24, 2026, were entitled to vote. The company published requisite advertisements in "Financial Express" and "Aajkaal" newspapers to inform shareholders about the e-voting facility and the AGM details. The votes were unlocked and authenticated in the presence of two witnesses from the Scrutinizer's firm after the conclusion of the AGM.
Historical Stock Returns for JK Agri Genetics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.40% | -2.55% | -1.58% | -12.63% | -24.16% | -65.00% |
What specific strategic initiatives or growth targets has Kuldeep Kumar Pandit outlined for his renewed three-year tenure as Whole-time Director?
How do the audited financial results for FY26 reflect the company's performance in the competitive agri-genetics sector, and what are the key drivers of revenue or margin changes?
Given the high promoter support, what is JK Agri Genetics' capital allocation strategy for the upcoming fiscal year regarding R&D investments, acquisitions, or dividend policies?


































